Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...] …
Year: 2023
Nearly one-quarter of the 200 provider audits planned for this year were closed by regulators with no adverse findings, they [...] …
Republicans and Democrats battled over Medicare price negotiation provisions under the Inflation Reduction Act (IRA) during a contentious Sept. 20 [...] …
![](https://340breport.com/wp-content/uploads/2023/09/Jason-Headshot-512x512-1.png)
I grew up in Salisbury, Maryland, a town of about 25,000 on the Delmarva Peninsula.
Read More »
Provider groups diverged over 340B Medicaid managed care provisions in a sweeping healthcare package on which the House of Representatives [...] …
The AIDS Healthcare Foundation (AHF) recently filed an appeal to an April district court dismissal of its case against Apexus, [...] …
There is no evidence to support federal allegations that a South Carolina community health center illegally diverts 340B-purchased drugs to [...] …
The future of a Republican drug shortages bill with 340B provisions remains unclear after it was examined in a contentious [...] …
Novo Nordisk will issue refunds to 340B covered entities for some purchases this year of its blockbuster injectable diabetes medication [...] …
The largest health insurer advocacy organization urged federal regulators to reject hospital-sought rules to limit the ability of Medicare Advantage [...] …